NL293572A
(en)
*
|
1962-06-07 |
|
|
|
DE2226703A1
(en)
|
1972-05-25 |
1973-12-13 |
Schering Ag |
NEW TETRAHYDROCARBAZOLE DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION
|
US4057559A
(en)
|
1973-10-01 |
1977-11-08 |
American Home Products Corporation |
Carbazole acetic acid derivatives
|
US4810699A
(en)
|
1987-02-20 |
1989-03-07 |
American Home Products Corporation |
Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
|
US4782076A
(en)
|
1988-03-01 |
1988-11-01 |
American Home Products Corporation |
Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, composition and use
|
PT95692A
(en)
|
1989-10-27 |
1991-09-13 |
American Home Prod |
PROCESS FOR THE PREPARATION OF INDOLE-, INDENO-, PYRANOINDOLE- AND TETRA-HYDROCARBAZOLE-ALCANOIC ACID DERIVATIVES, OR WHICH ARE USEFUL AS PLA2 INHIBITORS AND LIPOXIGENASE
|
US5221678A
(en)
|
1990-07-26 |
1993-06-22 |
Merck Frosst Canada, Inc. |
(quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
|
US5998499A
(en)
|
1994-03-25 |
1999-12-07 |
Dentsply G.M.B.H. |
Liquid crystalline (meth)acrylate compounds, composition and method
|
US5776967A
(en)
|
1996-07-26 |
1998-07-07 |
American Home Products Corporation |
Pyranoindole inhibitors of COX--2
|
US5830911A
(en)
|
1996-08-14 |
1998-11-03 |
American Home Products Corporation |
Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
|
US6861448B2
(en)
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
EP1177187B1
(en)
|
1999-04-28 |
2007-07-25 |
Sanofi-Aventis Deutschland GmbH |
Di-aryl acid derivatives as ppar receptor ligands
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
WO2002039987A2
(en)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
JP2004529100A
(en)
|
2001-01-30 |
2004-09-24 |
ユニバーシティ オブ バージニア パテント ファウンデーション |
Agonists and antagonists of sphingosine-1-phosphate receptor
|
WO2002079131A1
(en)
|
2001-03-29 |
2002-10-10 |
Kansai Research Institute, Inc. |
Optically active compound and photosensitive resin composition
|
ATE416762T1
(en)
|
2001-05-10 |
2008-12-15 |
Ono Pharmaceutical Co |
CARBOXIC ACID DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THESE AS ACTIVE INGREDIENTS
|
MXPA04002679A
(en)
|
2001-09-27 |
2004-07-30 |
Kyorin Seiyaku Kk |
Diaryl sulfide derivative, addition salt thereof, and immunosuppressant.
|
US7479504B2
(en)
|
2002-01-18 |
2009-01-20 |
Merck & Co., Inc. |
Edg receptor agonists
|
EP1469863A2
(en)
|
2002-01-18 |
2004-10-27 |
Merck & Co., Inc. |
Selective s1p1/edg1 receptor agonists
|
US20050239899A1
(en)
|
2002-01-18 |
2005-10-27 |
Wolfgang Fecke |
Beta-secretase inhibitors
|
AU2003218056A1
(en)
|
2002-03-01 |
2003-09-16 |
Merck & Co., Inc. |
Aminoalkylphosphonates and related compounds as edg receptor agonists
|
CA2477423A1
(en)
|
2002-03-01 |
2003-09-12 |
Merck & Co., Inc. |
Aminoalkylphosphonates and related compounds as edg receptor agonists
|
CA2488117A1
(en)
|
2002-06-17 |
2003-12-24 |
Merck & Co., Inc. |
1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
|
JPWO2004007472A1
(en)
|
2002-07-10 |
2005-11-17 |
小野薬品工業株式会社 |
CCR4 antagonist and pharmaceutical use thereof
|
EP1546110A4
(en)
|
2002-07-30 |
2008-03-26 |
Univ Virginia |
Compounds active in sphingosine 1-phosphate signaling
|
AU2003277576A1
(en)
|
2002-11-08 |
2004-06-07 |
Takeda Pharmaceutical Company Limited |
Receptor function controlling agent
|
AU2003297232B2
(en)
|
2002-12-20 |
2010-02-04 |
Merck Sharp & Dohme Corp. |
1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles
|
AU2004210697B2
(en)
|
2003-02-11 |
2007-10-18 |
Irm Llc |
Novel bicyclic compounds and compositions
|
KR101005171B1
(en)
|
2003-02-18 |
2011-01-04 |
교린 세이야꾸 가부시키 가이샤 |
Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators
|
MXPA05011539A
(en)
|
2003-04-30 |
2006-01-23 |
Inst For Pharm Discovery Inc |
Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b.
|
ES2383298T3
(en)
|
2003-04-30 |
2012-06-20 |
Novartis Ag |
Amino-propanol derivatives as sphingosine-1-phosphate receptor modulators
|
CA2523677A1
(en)
|
2003-04-30 |
2004-11-11 |
Novartis Ag |
Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
|
US20060252741A1
(en)
|
2003-05-15 |
2006-11-09 |
Colandrea Vincent J |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
WO2004104205A2
(en)
|
2003-05-16 |
2004-12-02 |
Merck & Co., Inc. |
Enzymatic preparation of chiral indole esters
|
MY150088A
(en)
|
2003-05-19 |
2013-11-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
JP4728962B2
(en)
|
2003-05-19 |
2011-07-20 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Immunosuppressive compounds and compositions
|
EP1638551B1
(en)
|
2003-05-19 |
2011-12-21 |
Irm Llc |
Immunosuppressant compounds and compositions
|
CA2524048C
(en)
|
2003-05-19 |
2013-06-25 |
Irm Llc |
Immunosuppressant compounds and compositions
|
GB0313612D0
(en)
|
2003-06-12 |
2003-07-16 |
Novartis Ag |
Organic compounds
|
JPWO2005012221A1
(en)
|
2003-08-04 |
2006-09-14 |
小野薬品工業株式会社 |
Diphenyl ether compound, its production method and use
|
WO2005021503A1
(en)
|
2003-08-28 |
2005-03-10 |
Novartis Ag |
Aminopropanol derivatives
|
CN101407471A
(en)
|
2003-08-29 |
2009-04-15 |
小野药品工业株式会社 |
Compound capable of binding S1P receptor and pharmaceutical use thereof
|
WO2005023771A1
(en)
|
2003-09-05 |
2005-03-17 |
Ono Pharmaceutical Co., Ltd. |
Chemokine receptor antagonist and medical use thereof
|
CN1859908A
(en)
|
2003-10-01 |
2006-11-08 |
默克公司 |
3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as S1P receptor agonists
|
US7638637B2
(en)
|
2003-11-03 |
2009-12-29 |
University Of Virginia Patent Foundation |
Orally available sphingosine 1-phosphate receptor agonists and antagonists
|
WO2005044780A1
(en)
|
2003-11-10 |
2005-05-19 |
Kyorin Pharmaceutical Co., Ltd. |
Aminocarboxylic acid derivative, addition salt thereof, and s1p receptor control agent
|
JP4773972B2
(en)
|
2003-12-17 |
2011-09-14 |
メルク・シャープ・エンド・ドーム・コーポレイション |
(3,4-Disubstituted) propanecarboxylic acids as S1P (Edg) receptor agonists
|
JP4766384B2
(en)
|
2003-12-19 |
2011-09-07 |
小野薬品工業株式会社 |
Compound having lysophosphatidic acid receptor antagonistic activity and use thereof
|
GB0329498D0
(en)
|
2003-12-19 |
2004-01-28 |
Novartis Ag |
Organic compounds
|
GB0401332D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
JP4740884B2
(en)
|
2004-02-24 |
2011-08-03 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Immunosuppressive compounds and compositions
|
KR20110136901A
(en)
|
2004-02-24 |
2011-12-21 |
상꾜 가부시키가이샤 |
Amino alcohol compound
|
AU2005219791B2
(en)
|
2004-03-05 |
2011-06-09 |
Msd K.K. |
Diaryl-substituted five-membered heterocycle derivative
|
GB0405289D0
(en)
|
2004-03-09 |
2004-04-21 |
Novartis Ag |
Organic compounds
|
JP5239071B2
(en)
|
2004-04-02 |
2013-07-17 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Asymmetric hydrogenation methods useful for the preparation of cycloalkanoindole derivatives
|
WO2005123677A1
(en)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
|
EP1760071A4
(en)
|
2004-06-23 |
2008-03-05 |
Ono Pharmaceutical Co |
Compound having s1p receptor binding potency and use thereof
|
PL1772145T3
(en)
|
2004-07-16 |
2011-08-31 |
Kyorin Seiyaku Kk |
Method of effectively using medicine and method concerning prevention of side effect
|
JP2007284350A
(en)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
Therapeutic agent for diabetes
|
WO2006010379A1
(en)
|
2004-07-29 |
2006-02-02 |
Actelion Pharmaceuticals Ltd. |
Novel thiophene derivatives as immunosuppressive agents
|
TW200611687A
(en)
|
2004-07-29 |
2006-04-16 |
Sankyo Co |
Pharmaceutical compositions used for immunosuppressant
|
CN1993333B
(en)
|
2004-08-04 |
2012-08-01 |
大正制药株式会社 |
Triazole derivative
|
US20060223866A1
(en)
|
2004-08-13 |
2006-10-05 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
|
WO2006020951A1
(en)
|
2004-08-13 |
2006-02-23 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
|
US7250441B2
(en)
|
2004-09-23 |
2007-07-31 |
Wyeth |
Carbazole and cyclopentaindole derivatives to treat infection with Hepatitis C virus
|
MX2007004262A
(en)
|
2004-10-12 |
2008-03-04 |
Forbes Medi Tech Res Inc |
Compounds and methods of treating insulin resistance and cardiomyopathy.
|
DK1650186T3
(en)
|
2004-10-22 |
2008-10-13 |
Sun Pharmaceutical Ind Ltd |
New dicarboxylic acid derivatives
|
WO2006047195A2
(en)
|
2004-10-22 |
2006-05-04 |
Merck & Co., Inc. |
2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists
|
JP2008520692A
(en)
|
2004-11-18 |
2008-06-19 |
ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー |
Heterocyclic substituted carboxylic acids
|
WO2006057448A1
(en)
|
2004-11-26 |
2006-06-01 |
Takeda Pharmaceutical Company Limited |
Arylalkanoic acid derivative
|
WO2006063033A2
(en)
|
2004-12-06 |
2006-06-15 |
University Of Virginia Patent Foundation |
Aryl amide sphingosine 1-phosphate analogs
|
PL1826197T3
(en)
|
2004-12-13 |
2012-06-29 |
Ono Pharmaceutical Co |
Aminocarboxylic acid derivative and medicinal use thereof
|
JP5798282B2
(en)
|
2005-01-25 |
2015-10-21 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
Mesogenic compound, liquid crystal medium and liquid crystal display
|
MX2007009848A
(en)
|
2005-02-14 |
2008-03-10 |
Univ Virginia |
Sphingosine 1- phos phate agonists comprising cycloalkanes and 5 -membered heterocycles substituted by amino and phenyl groups.
|
CN101180050B
(en)
|
2005-03-23 |
2011-07-27 |
埃科特莱茵药品有限公司 |
Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
|
RU2404178C2
(en)
|
2005-03-23 |
2010-11-20 |
Актелион Фармасьютиклз Лтд |
Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
|
JP5047941B2
(en)
|
2005-03-23 |
2012-10-10 |
アクテリオン ファーマシューティカルズ リミテッド |
Hydrogenated benzo (C) thiophene derivatives as immunomodulators
|
AU2006256968A1
(en)
|
2005-06-08 |
2006-12-14 |
Novartis Ag |
Polycyclic oxadiazoles or I soxazoles and their use as SIP receptor ligands
|
AU2006260573A1
(en)
|
2005-06-24 |
2006-12-28 |
Actelion Pharmaceuticals Ltd. |
Novel thiophene derivatives
|
TWI418350B
(en)
|
2005-06-24 |
2013-12-11 |
Sankyo Co |
Use of pharmaceutical compositions comprising ppar modulator
|
US20070060573A1
(en)
|
2005-08-10 |
2007-03-15 |
Lars Wortmann |
Acyltryptophanols
|
AU2006283175A1
(en)
|
2005-08-23 |
2007-03-01 |
Irm Llc |
Immunosuppressant compounds and compositions
|
WO2007037196A1
(en)
|
2005-09-29 |
2007-04-05 |
Yamamoto Chemicals, Inc. |
Indoline compound and method for producing same
|
AR057894A1
(en)
|
2005-11-23 |
2007-12-26 |
Actelion Pharmaceuticals Ltd |
THIOPHEN DERIVATIVES
|
AU2006317689B2
(en)
|
2005-11-23 |
2013-07-25 |
Epix Delaware, Inc. |
S1P receptor modulating compounds and use thereof
|
TWI404706B
(en)
|
2006-01-11 |
2013-08-11 |
Actelion Pharmaceuticals Ltd |
Novel thiophene derivatives
|
TW200736234A
(en)
|
2006-01-17 |
2007-10-01 |
Astrazeneca Ab |
Chemical compounds
|
EP1979345B1
(en)
|
2006-01-24 |
2009-11-04 |
Actelion Pharmaceuticals Ltd. |
Novel pyridine derivatives
|
GB0601744D0
(en)
|
2006-01-27 |
2006-03-08 |
Novartis Ag |
Organic compounds
|
TWI389683B
(en)
|
2006-02-06 |
2013-03-21 |
Kyorin Seiyaku Kk |
A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
|
CA2641718A1
(en)
|
2006-02-09 |
2007-08-16 |
University Of Virginia Patent Foundation |
Bicyclic sphingosine 1-phosphate analogs
|
TW200806611A
(en)
|
2006-02-09 |
2008-02-01 |
Daiichi Seiyaku Co |
Novel amidopropionic acid derivatives and medicine containing the same
|
US20070191371A1
(en)
|
2006-02-14 |
2007-08-16 |
Kalypsys, Inc. |
Heterocyclic modulators of ppar
|
CN101460458A
(en)
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
WO2007095561A2
(en)
|
2006-02-15 |
2007-08-23 |
Allergan, Inc. |
Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
|
EP1991535A1
(en)
|
2006-02-21 |
2008-11-19 |
University Of Virginia Patent Foundation |
Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as sip receptor agonists
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
CA2646430A1
(en)
|
2006-03-14 |
2007-09-20 |
Amgen Inc. |
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
|
CA2646469A1
(en)
|
2006-03-21 |
2007-09-27 |
Epix Delaware, Inc. |
S1p receptor modulating compounds
|
JP2007262009A
(en)
|
2006-03-29 |
2007-10-11 |
Dai Ichi Seiyaku Co Ltd |
Heteroaryl lower carboxylic acid derivative
|
ES2453372T3
(en)
|
2006-04-03 |
2014-04-07 |
Astellas Pharma Inc. |
Oxadiazole derivatives as S1P1 agonists
|
GB0607389D0
(en)
|
2006-04-12 |
2006-05-24 |
Novartis Ag |
Organic compounds
|
WO2007132307A1
(en)
|
2006-05-09 |
2007-11-22 |
Pfizer Products Inc. |
Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
|
US20090324581A1
(en)
|
2006-05-09 |
2009-12-31 |
Daiichi Sankyo Company Limited |
Heteroarylamide lower carboxylic acid derivative
|
WO2007129473A1
(en)
|
2006-05-09 |
2007-11-15 |
Daiichi Sankyo Company, Limited |
Bicyclic aryl derivative
|
JP2009545597A
(en)
|
2006-08-01 |
2009-12-24 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
Sphingosine-1-phosphate receptor (SLP) agonist
|
AR062156A1
(en)
|
2006-08-01 |
2008-10-22 |
Praecis Pharm Inc |
S1P-1 RECEPTOR AGONIST AND SELECTIVE COMPOUNDS
|
JP2009545630A
(en)
|
2006-08-04 |
2009-12-24 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
Compound
|
NZ574011A
(en)
|
2006-08-08 |
2011-10-28 |
Kyorin Seiyaku Kk |
Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient
|
WO2008024196A1
(en)
|
2006-08-24 |
2008-02-28 |
Praecis Pharmaceuticals Incorporated |
Chemical compounds
|
JP2009269819A
(en)
|
2006-08-25 |
2009-11-19 |
Asahi Kasei Pharma Kk |
Amine compound
|
AU2007292993B2
(en)
|
2006-09-07 |
2013-01-24 |
Idorsia Pharmaceuticals Ltd |
Pyridin-4-yl derivatives as immunomodulating agents
|
BRPI0716815A2
(en)
|
2006-09-07 |
2013-11-05 |
Allergan Inc |
HETEROATOMATIC POST HAVING AGONIST AND / OR ANTAGONIST BIOLOGICAL ACTIVITY OF SPINPHOSINE-1-PHOSPHATE (S1P) RECEIVER
|
AR061841A1
(en)
|
2006-09-07 |
2008-09-24 |
Actelion Pharmaceuticals Ltd |
DERIVATIVES OF THIOFEN-OXADIAZOLS, AGONISTS OF THE S1P1 / EDG1 RECEPTOR, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES AS IMMUNOMODULATING AGENTS.
|
CN101511783A
(en)
|
2006-09-08 |
2009-08-19 |
诺瓦提斯公司 |
N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
|
RU2442780C2
(en)
|
2006-09-21 |
2012-02-20 |
Актелион Фармасьютиклз Лтд |
Phenyl derivatives and their application as immunomodulators
|
AU2007334436A1
(en)
|
2006-12-15 |
2008-06-26 |
Abbott Laboratories |
Novel oxadiazole compounds
|
TW200838497A
(en)
|
2006-12-21 |
2008-10-01 |
Abbott Lab |
Sphingosine-1-phosphate receptor agonist and antagonist compounds
|
GB0625648D0
(en)
|
2006-12-21 |
2007-01-31 |
Glaxo Group Ltd |
Compounds
|
JO2701B1
(en)
*
|
2006-12-21 |
2013-03-03 |
جلاكسو جروب ليميتد |
Compounds
|
KR20090101307A
(en)
|
2007-01-11 |
2009-09-24 |
알러간, 인코포레이티드 |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
|
WO2008091967A1
(en)
|
2007-01-26 |
2008-07-31 |
Smithkline Beecham Corporation |
Chemical compounds
|
WO2008097819A2
(en)
|
2007-02-05 |
2008-08-14 |
Smithkline Beecham Corporation |
Chemical compounds
|
DK2125797T3
(en)
|
2007-03-16 |
2014-02-10 |
Actelion Pharmaceuticals Ltd |
AMINOPYRIDINE DERIVATIVES AS S1P1 / EDG1 RECEPTOR AGONISTS
|
EP2121648A2
(en)
|
2007-03-21 |
2009-11-25 |
EPIX Pharmaceuticals, Inc. |
S1p receptor modulating compounds and use thereof
|
KR20090130062A
(en)
|
2007-04-19 |
2009-12-17 |
글락소 그룹 리미티드 |
Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
|
EP2014653A1
(en)
|
2007-06-15 |
2009-01-14 |
Bioprojet |
Novel dicarboxylic acid derivatives as S1P1 receptor agonists
|
US20090069288A1
(en)
|
2007-07-16 |
2009-03-12 |
Breinlinger Eric C |
Novel therapeutic compounds
|
WO2009019506A1
(en)
|
2007-08-03 |
2009-02-12 |
Astrazeneca Ab |
Heterocyclyc sulfonamides having edg-1 antagonistic activity
|
JP5508265B2
(en)
|
2007-08-08 |
2014-05-28 |
メルク セローノ ソシエテ アノニム |
6-amino-pyrimidine-4-carboxamide derivatives and related compounds that bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis
|
TW200930368A
(en)
|
2007-11-15 |
2009-07-16 |
Astrazeneca Ab |
Bis-(sulfonylamino) derivatives in therapy
|
EP2222668B1
(en)
|
2007-12-18 |
2011-11-02 |
Arena Pharmaceuticals, Inc. |
Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
|
AU2009206733A1
(en)
*
|
2008-01-25 |
2009-07-30 |
Arena Pharmaceuticals, Inc. |
Dihydro- 1H- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as S1P1 agonists
|
AR070398A1
(en)
|
2008-02-22 |
2010-03-31 |
Gruenenthal Chemie |
INDOL SUBSTITUTED DERIVATIVES
|
NZ589617A
(en)
|
2008-05-14 |
2012-06-29 |
Scripps Research Inst |
3-(Inden-4-yl)-5-(phenyl)-1,2,4-oxadiazole and 3-(tetralin-5-yl)-5-(phenyl)-1,2,4-oxadiazole derivatives
|
WO2009151626A1
(en)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
|
WO2009151621A1
(en)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
|
HUE030424T2
(en)
|
2008-07-23 |
2017-05-29 |
Arena Pharm Inc |
SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
|
SI2342205T1
(en)
*
|
2008-08-27 |
2016-09-30 |
Arena Pharmaceuticals, Inc. |
Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
|
BRPI0922135B1
(en)
*
|
2008-12-05 |
2021-07-13 |
Astellas Pharma Inc |
2H-CROMENE COMPOUND OR A SALT THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING SUCH COMPOUND AND USE OF THE SAME TO PREVENT OR TREAT A DISEASE INDUCED BY UNDESIRABLE LYMPHOCYTE INFILTRATION ASSOCIATED WITH S1P1
|
CA2749960A1
(en)
|
2009-02-10 |
2010-08-19 |
Abbott Laboratories |
Agonists and antagonists of the s1p5 receptor, and methods of uses thereof
|
WO2011005290A1
(en)
|
2009-06-23 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Disubstituted oxadiazole derivatives useful in the treatment of autoimmune and inflammatory disorders
|
WO2011005295A1
(en)
|
2009-06-24 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
|
EP2597089A1
(en)
|
2009-10-29 |
2013-05-29 |
Bristol-Myers Squibb Company |
Tricyclic heterocyclic compounds
|
ES2937386T3
(en)
|
2010-01-27 |
2023-03-28 |
Arena Pharm Inc |
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts of same
|
WO2011109471A1
(en)
*
|
2010-03-03 |
2011-09-09 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
|
WO2012015758A2
(en)
|
2010-07-30 |
2012-02-02 |
Saint Louis University |
Methods of treating pain
|